S. Bar‐Yehuda, L. Madi, D. Silberman, Slosman Gery, Maya Shkapenuk, P. Fishman
{"title":"CF101是A3腺苷受体的激动剂,可增强5-氟尿嘧啶在结肠癌小鼠模型中的化疗效果。","authors":"S. Bar‐Yehuda, L. Madi, D. Silberman, Slosman Gery, Maya Shkapenuk, P. Fishman","doi":"10.1016/s1359-6349(04)80396-3","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":48716,"journal":{"name":"Neoplasia","volume":"17 1","pages":"85-90"},"PeriodicalIF":6.3000,"publicationDate":"2004-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"46","resultStr":"{\"title\":\"CF101, an agonist to the A3 adenosine receptor, enhances the chemotherapeutic effect of 5-fluorouracil in a colon carcinoma murine model.\",\"authors\":\"S. Bar‐Yehuda, L. Madi, D. Silberman, Slosman Gery, Maya Shkapenuk, P. Fishman\",\"doi\":\"10.1016/s1359-6349(04)80396-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":48716,\"journal\":{\"name\":\"Neoplasia\",\"volume\":\"17 1\",\"pages\":\"85-90\"},\"PeriodicalIF\":6.3000,\"publicationDate\":\"2004-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"46\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Neoplasia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/s1359-6349(04)80396-3\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neoplasia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/s1359-6349(04)80396-3","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Neoplasia publishes the results of novel investigations in all areas of oncology research. The title Neoplasia was chosen to convey the journal’s breadth, which encompasses the traditional disciplines of cancer research as well as emerging fields and interdisciplinary investigations. Neoplasia is interested in studies describing new molecular and genetic findings relating to the neoplastic phenotype and in laboratory and clinical studies demonstrating creative applications of advances in the basic sciences to risk assessment, prognostic indications, detection, diagnosis, and treatment. In addition to regular Research Reports, Neoplasia also publishes Reviews and Meeting Reports. Neoplasia is committed to ensuring a thorough, fair, and rapid review and publication schedule to further its mission of serving both the scientific and clinical communities by disseminating important data and ideas in cancer research.